247 ORAL BRAF V600E confers resistance to cetuximab or panitumumab in metastatic colorectal cancer

Title
247 ORAL BRAF V600E confers resistance to cetuximab or panitumumab in metastatic colorectal cancer
Authors
Keywords
-
Journal
EJC SUPPLEMENTS
Volume 6, Issue 12, Pages 81
Publisher
Elsevier BV
Online
2008-10-22
DOI
10.1016/s1359-6349(08)72181-5

Ask authors/readers for more resources

Publish scientific posters with Peeref

Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.

Learn More

Ask a Question. Answer a Question.

Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.

Get Started